BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+20.82%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.42B
AUM Growth
+$2.42B
Cap. Flow
+$150M
Cap. Flow %
6.2%
Top 10 Hldgs %
42.31%
Holding
83
New
4
Increased
11
Reduced
18
Closed
3

Top Buys

1
IONS icon
Ionis Pharmaceuticals
IONS
$70.6M
2
THRD
Third Harmonic Bio
THRD
$66.4M
3
ALLK
Allakos
ALLK
$30.6M
4
VERV
Verve Therapeutics
VERV
$22.3M
5
RVMD icon
Revolution Medicines
RVMD
$19.7M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$32.5M
2
XENE icon
Xenon Pharmaceuticals
XENE
$25.2M
3
EQRX
EQRx, Inc. Common Stock
EQRX
$23M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
$13.4M
5
MRUS icon
Merus
MRUS
$12.8M

Sector Composition

1 Healthcare 98.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NUVL icon
26
Nuvalent
NUVL
$5.74B
$32.4M 1.34%
1,666,282
– –
FDMT icon
27
4D Molecular Therapeutics
FDMT
$302M
$32.2M 1.33%
4,007,413
– –
COGT icon
28
Cogent Biosciences
COGT
$1.83B
$31.1M 1.28%
2,084,824
-172,350
-8% -$2.57M
ALLK
29
DELISTED
Allakos
ALLK
$30.6M 1.27%
+5,006,921
New +$30.6M
EQRX
30
DELISTED
EQRx, Inc. Common Stock
EQRX
$29.7M 1.23%
6,008,187
-4,640,340
-44% -$23M
ANTX icon
31
AN2 Therapeutics
ANTX
$35.3M
$28.1M 1.16%
1,616,665
– –
CNTA
32
Centessa Pharmaceuticals
CNTA
$2.13B
$27.7M 1.14%
6,894,345
– –
CNCE
33
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$24.3M 1%
3,629,000
– –
ACIU icon
34
AC Immune
ACIU
$227M
$23.5M 0.97%
7,428,379
– –
ANNX icon
35
Annexon
ANNX
$225M
$23.4M 0.97%
3,780,694
– –
VERV
36
DELISTED
Verve Therapeutics
VERV
$22.3M 0.92%
+650,000
New +$22.3M
TYRA icon
37
Tyra Biosciences
TYRA
$657M
$21.7M 0.9%
2,472,327
– –
OLMA icon
38
Olema Pharmaceuticals
OLMA
$432M
$21M 0.87%
7,611,503
– –
JANX icon
39
Janux Therapeutics
JANX
$1.38B
$19.9M 0.82%
1,470,334
– –
STRO icon
40
Sutro Biopharma
STRO
$85.6M
$19.1M 0.79%
3,447,946
– –
ETNB icon
41
89bio
ETNB
$1.37B
$18.2M 0.75%
3,143,682
-754,318
-19% -$4.37M
RAIN
42
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$17.2M 0.71%
3,526,729
– –
VSTM icon
43
Verastem
VSTM
$585M
$17M 0.7%
19,974,658
– –
VIGL
44
DELISTED
Vigil Neuroscience
VIGL
$16.5M 0.68%
+1,813,633
New +$16.5M
REPL icon
45
Replimune Group
REPL
$460M
$16M 0.66%
926,529
– –
EPIX icon
46
ESSA Pharma
EPIX
$11.2M
$15.9M 0.66%
8,748,629
+5,050,000
+137% +$9.19M
VIRX
47
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$15.4M 0.64%
3,614,662
– –
SLN
48
Silence Therapeutics
SLN
$237M
$14.9M 0.62%
1,508,416
+841,750
+126% +$8.31M
OVID icon
49
Ovid Therapeutics
OVID
$94.6M
$12.6M 0.52%
6,851,051
– –
WHWK
50
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$12.4M 0.51%
879,085
– –
1
2
3 4